1967
DOI: 10.1254/jjp.17.381
|View full text |Cite
|
Sign up to set email alerts
|

HYPERSENSITIVE TOXICITY OF 5-n-BUTYL-1-CYCLOHEXYL-2, 4, 6-TRIOXOPERHYDROPYRIMIDINE IN THE PREGNANT RAT

Abstract: 5-n-Butyl-l-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP), a new antipyretic antiphlogistic agent, has been reported to differ from aminopyrine and phenylbutazone in lack of central convulsion in mice and rats as well as in mildness of the convulsion caused by the toxic doses in rabbits and dogs (1). Respiratory depression was the usual cause of death following excessive doses of BCP. The oral subchronic toxicity of BCP, amino pyrine and phenylbutazone in rats was reported by Okamoto (2) and Araki (3). Accor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1968
1968
2004
2004

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…These metabolic effects including inhibition of corticosteroid biotransformation, uncoupling of oxidative phosphorylation, glycogenolysis, alteration of electrolyte balance and inhibition of mucopolysaccharide biosynthesis seem to merit attention in relation to their antiphlogistic activities (1-3). Tanabe and his co-workers (4,5) have shown that a death caused by larger doses of phenylbutazone and 5-n-butyl-l-cyclohexyl-2, 4, 6-trioxoperhydropyrimidine (BCP) is probably due to the decompensation of adrenocortical function, since repeated administrations of these agents produce the diffuse hemorrhage and proliferation of adrenal cortex in the rat. Korus et al (6) have reported that in the inactivation process of cortisone phenylbutazone not only inhibits the transformation of the a,f-unsaturated ketonic group of ring A, but also the degradation of the ce-ketolic side chain of ring D. However, Dirscherl and Lutzmann (7) have observed only the inhibitory effect of aminophenazone on the reduction of ring A.…”
mentioning
confidence: 99%
“…These metabolic effects including inhibition of corticosteroid biotransformation, uncoupling of oxidative phosphorylation, glycogenolysis, alteration of electrolyte balance and inhibition of mucopolysaccharide biosynthesis seem to merit attention in relation to their antiphlogistic activities (1-3). Tanabe and his co-workers (4,5) have shown that a death caused by larger doses of phenylbutazone and 5-n-butyl-l-cyclohexyl-2, 4, 6-trioxoperhydropyrimidine (BCP) is probably due to the decompensation of adrenocortical function, since repeated administrations of these agents produce the diffuse hemorrhage and proliferation of adrenal cortex in the rat. Korus et al (6) have reported that in the inactivation process of cortisone phenylbutazone not only inhibits the transformation of the a,f-unsaturated ketonic group of ring A, but also the degradation of the ce-ketolic side chain of ring D. However, Dirscherl and Lutzmann (7) have observed only the inhibitory effect of aminophenazone on the reduction of ring A.…”
mentioning
confidence: 99%